Bogart Wealth’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$56.3K Buy
+1,009
New +$54.6K ﹤0.01% 531
2026
Q1
– Sell
-16,774
Closed -$500K – 1894
2025
Q4
$500K Buy
+16,774
New +$548K 0.02% 169

Other funds holding TGTX

Bogart Wealth's TGTX Position: Q3 2026 in Review

Bogart Wealth opened a new position in TG Therapeutics (TGTX) in Q3 2026: 1,009 shares worth $56.3K. The stake represents ﹤0.01% of the portfolio and ranks #531 among its holdings. This is a return to the name: Bogart Wealth previously reported a position in TGTX as recently as Q4 2025.

Bogart Wealth first reported a position in TGTX in Q4 2025 and has held it in 2 quarters since. The position peaked at $500K in Q4 2025. 454 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.

  • Bogart Wealth held 1,009 shares of TG Therapeutics worth $56.3K as of Q3 2026.
  • TG Therapeutics was a new Bogart Wealth position in Q3 2026.
  • TG Therapeutics made up ﹤0.01% of Bogart Wealth's portfolio in Q3 2026, its #531 holding.
  • Bogart Wealth first reported a position in TG Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Bogart Wealth's TG Therapeutics position peaked at $500K in Q4 2025.
  • 454 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.

Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.